Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D4-receptor antagonist cinalukast

Journal of Allergy and Clinical Immunology

Volumn 99, Issue 2, 1997, Pages 210-215

  Ädelroth, Ellinor ^a,c   Inman, Mark D ^a   Summers, Edie ^a   Pace, Dan ^b   Modi, Marlene ^b   O'Byrne, Paul M ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b HOFFMANN LA ROCHE INC   (United States)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Asthma; bronchoconstriction; cysteinyl leukotriene; exercise

Indexed keywords

CINALUKAST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EXERCISE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0031054953     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70098-8     Document Type: Article

References (22)

1. Anderson SD. Exercise-induced asthma: the state of the art. Chest 1985;(suppl 87):191-5.
2. McFadden ER Jr. Exercise-induced asthma: assessment of current etiological concept. Chest 1987;(suppl 91):151-7.
3. Gilbert IA, Fouke JM, McFadden ER Jr. Heat and water flux in the intrathoracic airways and exercise-induced asthma. J Appl Physiol 1987;63:1681-91.
4. Finnerty JP, Holgate ST. Evidence for the roles of histamine and prostaglandins as mediators in exercise in exercise-induced asthma: the inhibitory effect of terfenadine and flurbiprofen alone and in combination. Eur Respir J 1990;3:540-7.
5. 4: potency, time course, and effect of aspirin therapy. JAMA 1983;249:284-7.
6. 4 and to methacholine in patients with asthma and normal subjects. N Engl J Med 1986;315:480-4.
7. Kikawa Y, Miyanomae T, Saito M, Nakai A, Shigematsu Y, Hosoi SE. Urinary leukotriene E4 after exercise challenge in children with asthma. J Allergy Clin Immunol 1992;89:1111-9.
8. Taylor IK, Wellings R, Taylor GW, Fuller RW. Urinary leukotriene E4 excretion in exercise-induced bronchoconstriction. J Appl Physiol 1992;73:743-8.
9. Manning PJ, Watson RM, Malgorskee D.I, Williams VC, Schwartz JL, O'Byrne PM. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. N Engl J Med 1990;323:1736-9.
10. Finnerty JP, Wood-Baker R, Thomson H, Holgate ST. Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist. Am Rev Respir Dis 1992;145:746-9.
11. Robuschi M, Riva E, Fuccella LM, Vida E, Barnabe R, Rossi ME. Prevention of exercise-induced bronchoccnstriction by a new leukotriene antagonist (SK&F 104353). A couble-blind study versus disodium cromoglycate and placebo. Am Rev Respir Dis 1992;145:1285-8.
12. 4 receptor antagonist ICI 204,219 against exercise-induced asthma. Am Rev Respir Dis 1993;1413-8.
13. 4. J Pharmacol Exp Ther 1991;259:751-8.
14. Morris JF, Koski A, Johnson LC. Spirorr eter standards for healthy non-smoking adults. Am Rev Respir Dis 1971;103:57-67.
15. Inman MD, Watson RM, Woolley KL, Manning PJ, O'Byrne PM. Reproducibility of bronchoconstriction Following dry air exercise challenge [abstract]. Am Rev Respir Dis 1994;149:A1048.
16. Anderson S. A simple guide to clinical exercise testing. Aust NZ J Med 1984;14:803-6.
17. Jones N. Clinical exercise testing. 3rd ed. Philadelphia: WB Saunders, 1988:135-44.
18. Jones B, Kenward M. Design and anilysis of cross-over trials. London: Chapman and Hall Ltd, 1989:197-9.
19. Keppel G. Design and analysis: a researcher's handbook. 2nd ed. Englewood Cliffs (NJ): Prentice Hall, 1982.
20. National Heart and Lung Association, US Department of Health. Guidelines for the diagnosis and management of asthma. 1991;No. 91.
21. Malo JL, Ghgezzo H, Trudeau C, LAcheveque J, Cartier A. Salmeterol, a new inhaled beta 2-adrenergic agonist, has longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction. J Allergy Clin Immunol 1992;89:567-74.
22. Anderson SD, Rodwell L, DuToit J, Young IH. Duration of protection by inhaled salmeterol in exercise-induced asthma. Chest 1991;100:1254-60.